Table I. Summary of the number of proteins analyzed for each dataset.
| Data set1 | Data set2 | Data set3 | |
|---|---|---|---|
| Number of samples used | 18 | 25 | 8 |
| Total proteins tested | 90 | 402 | 238 |
| Proseek Multiplex Oncology I V2 panel | 90 | 67 | 90 |
| Proseek Multiplex Inflammation I panel | - | 80 | - |
| Proseek Multiplex CVD I panel | - | 49 | - |
| Cancer panel | - | 71 | 72 |
| Cellular Pathways panel | - | 77 | 76 |
| Neurology panel | - | 58 | - |
| Total proteins detecteda | 58 | 264 | 127 |
| Cell lines | |||
| Number of cell line groups tested | 3 | 7 | - |
| Proteins detecteda | 58 | 257 | - |
| EVs | |||
| Number of exosome groups tested | 3 | 7 | 2 |
| Proteins detecteda | 37 | 134 | 127 |
a Number of proteins detected in more than 50% of the sample from at least one group.